Starting ADHD medication is not a one-time decision followed by a prescription on autopilot. Follow-up is how a patient and prescriber check whether the plan is helping, notice unwanted effects, and make adjustments together. Not every adult with ADHD chooses medication, and medication is only one possible part of care. For those who do begin it, regular check-ins are a normal part of thoughtful treatment—not a sign that something has gone wrong.

Early visits are about finding the right fit

A first prescription rarely answers every question. A clinician may start with a cautious plan and arrange a follow-up to hear what has changed in real life: Is it easier to finish a work task, remember appointments, or manage a household routine? Are the goals the patient chose actually improving? Is the medicine wearing off at a difficult time of day? Are there new problems with sleep, appetite, mood, or physical comfort?

The point is not to chase a perfect score or expect a dramatic transformation. The National Institute of Mental Health (NIMH) describes ADHD treatment as something that may involve medication, psychotherapy, or a combination; people may need to try different approaches to find what works for them. The right plan depends on the individual, their health history, priorities, and preferences. A person who notices little benefit—or finds the downsides outweigh the benefit—should bring that information to the prescriber rather than changing the dose independently.

What happens during a check-in?

Expect a practical conversation, not a test you can pass or fail. The clinician may ask about specific situations rather than “focus” in the abstract: getting started, finishing, shifting between tasks, listening in meetings, or keeping track of responsibilities. Together, patient and clinician can compare the original goals with what is happening now and decide whether the next step is to continue, adjust, pause, or reconsider the approach.

During an early dose-adjustment period, check-ins may be more frequent than after a plan is stable. The timing varies by medication, clinical circumstances, and local practice. NICE guidance recommends recording symptoms, impairment, and adverse effects during dose changes and titrating against both benefit and tolerability. It also advises more frequent monitoring during titration for people with certain coexisting mental or physical health conditions. NICE is a UK guideline, not a universal US schedule, but its emphasis on tracking outcomes and side effects is useful for understanding why follow-up matters.

Side effects deserve a real conversation

A follow-up is also a chance to report changes that may be easy to dismiss or hard to connect to treatment. For prescription stimulants, the U.S. Food and Drug Administration (FDA) lists possible side effects that include reduced appetite, trouble sleeping, headache, stomachache, irritability, faster heart rate, and higher blood pressure. That list does not mean every patient will experience them; a clinician can help assess what is happening and whether it may be related to medication or something else.

Physical measurements can be part of safe monitoring. NICE recommends checking heart rate and blood pressure before and after each dose change and every six months, and measuring weight every six months in adults taking ADHD medication. These are recommendations from UK guidance; a US prescriber’s schedule may differ depending on the medicine, a person’s history, and other clinical factors. Routine follow-up is also not the same as needing every possible test: NICE does not recommend routine blood tests or electrocardiograms without a clinical reason. Patients can ask what monitoring is appropriate for their specific prescription.

Sleep and appetite are worth mentioning even if they seem manageable. So are mood changes, anxiety, headaches, heart palpitations, or a change in how the medication seems to work over the day. Share the timing and context, if possible. A short note on when a change began, how often it happens, and what else was going on can give the clinician more useful information than “I feel off.” Seek urgent care for severe or sudden symptoms; do not wait for a routine appointment if you believe you may be having a medical emergency.

Bring useful observations—not a perfect diary

ADHD itself can make remembering treatment details difficult. A reminder, notes app, calendar entry, or a trusted person’s observation may help, if the patient wants that support. Before a visit, it can be useful to note:

• What feels easier, harder, or unchanged since starting treatment?
• When do benefits or unwanted effects appear, and how long do they last?
• Have sleep, appetite, mood, or daily routines changed?
• Have there been missed doses, practical barriers, or questions about how to take the prescription?
• What outcome matters most to you before the next visit?

There is no need to make the report sound positive or negative. “I can start tasks sooner, but I still lose track of time” is more useful than trying to decide whether treatment is a success. If the plan is not helping enough, the clinician can review possible explanations and options. That may include changing the plan, strengthening non-medication supports, or revisiting whether another condition is affecting attention.

Follow-up is part of shared decision-making

ADHD can occur alongside anxiety, depression, sleep problems, substance use, or other health conditions. The CDC’s overview of ADHD in adults notes that some of these can cause similar symptoms or co-occur with ADHD, and may call for medical or psychological assessment. If concentration or sleep changes, that context matters; a medication appointment can be a place to discuss it rather than assume every difficulty has one cause.

Follow-up can also address safe use. The FDA advises taking prescription stimulants exactly as prescribed, not sharing them, and storing them securely. Those practical steps matter for patients and for anyone else in the household who might encounter the medicine.

Medication is not the only route to support, and choosing it does not commit someone to ignoring other needs. Psychotherapy, skills-based supports, environmental changes, and routine adjustments may also be part of care. For adults exploring their options, adult ADHD treatment and medication management can be one starting point for learning what a clinician-led plan may involve.

The most useful follow-up is an honest two-way conversation: what has improved, what has not, what feels uncomfortable, and what the patient wants to work on next. That information helps keep treatment responsive to the person—not just the prescription.

This article is for general information only and is not medical advice. Discuss medication questions or changes with a qualified health professional.

About John C. Shershow

Dr. John C. Shershow is a psychiatrist whose practice focuses on the evaluation and treatment of adults with attention-deficit/hyperactivity disorder (ADHD). He has served on the faculty of Harvard Medical School and Massachusetts General Hospital, as Associate Dean of SUNY Downstate Medical School, and as a surveyor and faculty member of the Joint Commission. He is a Distinguished Life Fellow of the American Psychiatric Association. His approach emphasizes careful diagnosis, individualized treatment planning, and ongoing follow-up when medication is part of care.